Literature DB >> 25617052

Increased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury.

Paul W Fisher1, Yingjie Zhao, Mario C Rico, Vicky S Massicotte, Christine K Wade, Judith Litvin, Geoffrey M Bove, Steven N Popoff, Mary F Barbe.   

Abstract

Key clinical features of cumulative trauma disorders include pain, muscle weakness, and tissue fibrosis, although the etiology is still under investigation. Here, we characterized the temporal pattern of altered sensorimotor behaviors and inflammatory and fibrogenic processes occurring in forearm muscles and serum of young adult, female rats performing an operant, high repetition high force (HRHF) reaching and grasping task for 6, 12, or 18 weeks. Palmar mechanical sensitivity, cold temperature avoidance and spontaneous behavioral changes increased, while grip strength declined, in 18-week HRHF rats, compared to controls. Flexor digitorum muscles had increased MCP-1 levels after training and increased TNFalpha in 6-week HRHF rats. Serum had increased IL-1beta, IL-10 and IP-10 after training. Yet both muscle and serum inflammation resolved by week 18. In contrast, IFNγ increased at week 18 in both muscle and serum. Given the anti-fibrotic role of IFNγ, and to identify a mechanism for the continued grip strength losses and behavioral sensitivities, we evaluated the fibrogenic proteins CCN2, collagen type I and TGFB1, as well as the nociceptive/fibrogenic peptide substance P. Each increased in and around flexor digitorum muscles and extracellular matrix in the mid-forearm, and in nerves of the forepaw at 18 weeks. CCN2 was also increased in serum at week 18. At a time when inflammation had subsided, increases in fibrogenic proteins correlated with sensorimotor declines. Thus, muscle and nerve fibrosis may be critical components of chronic work-related musculoskeletal disorders. CCN2 and substance P may serve as potential targets for therapeutic intervention, and CCN2 as a serum biomarker of fibrosis progression.

Entities:  

Year:  2015        PMID: 25617052      PMCID: PMC4414846          DOI: 10.1007/s12079-015-0263-0

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  103 in total

1.  Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.

Authors:  Sharon G Adler; Sherwyn Schwartz; Mark E Williams; Carlos Arauz-Pacheco; Warren K Bolton; Tyson Lee; Dongxia Li; Thomas B Neff; Pedro R Urquilla; K Lea Sewell
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

2.  Intra-articular administration of tachykinin NK₁ receptor antagonists reduces hyperalgesia and cartilage destruction in the inflammatory joint in rats with adjuvant-induced arthritis.

Authors:  Takuya Uematsu; Atsushi Sakai; Hiromoto Ito; Hidenori Suzuki
Journal:  Eur J Pharmacol       Date:  2011-07-06       Impact factor: 4.432

Review 3.  Relation of substance P to pain transmission: neurophysiological evidence.

Authors:  J L Henry
Journal:  Ciba Found Symp       Date:  1982

Review 4.  Exploring anti-TGF-β therapies in cancer and fibrosis.

Authors:  Lukas J A C Hawinkels; Peter Ten Dijke
Journal:  Growth Factors       Date:  2011-06-30       Impact factor: 2.511

5.  A prospective study of computer users: I. Study design and incidence of musculoskeletal symptoms and disorders.

Authors:  Fredric Gerr; Michele Marcus; Cindy Ensor; David Kleinbaum; Susan Cohen; Alicia Edwards; Eileen Gentry; Daniel J Ortiz; Carolyn Monteilh
Journal:  Am J Ind Med       Date:  2002-04       Impact factor: 2.214

6.  Expression of sensory neuropeptides in tendon is associated with failed healing and activity-related tendon pain in collagenase-induced tendon injury.

Authors:  Pauline Po-Yee Lui; Lai-Shan Chan; Sai-Chuen Fu; Kai-Ming Chan
Journal:  Am J Sports Med       Date:  2010-02-05       Impact factor: 6.202

7.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

8.  Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.

Authors:  Julie T Daniels; Gregory S Schultz; Timothy D Blalock; Qian Garrett; Gary R Grotendorst; Nicholas M Dean; Peng T Khaw
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

9.  Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.

Authors:  Fernanda C Teodoro; Marcos F Tronco Júnior; Aleksander R Zampronio; Alessandra C Martini; Giles A Rae; Juliana G Chichorro
Journal:  Neuropeptides       Date:  2012-11-22       Impact factor: 3.286

10.  Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro.

Authors:  Sonali Sonnylal; Shiwen Xu; Helen Jones; Angela Tam; Vivek R Sreeram; Markella Ponticos; Jill Norman; Pankaj Agrawal; David Abraham; Benoit de Crombrugghe
Journal:  J Cell Sci       Date:  2013-03-22       Impact factor: 5.285

View more
  25 in total

1.  YAP/TAZ initiate and maintain Schwann cell myelination.

Authors:  Matthew Grove; Hyukmin Kim; Maryline Santerre; Alexander J Krupka; Seung Baek Han; Jinbin Zhai; Jennifer Y Cho; Raehee Park; Michele Harris; Seonhee Kim; Bassel E Sawaya; Shin H Kang; Mary F Barbe; Seo-Hee Cho; Michel A Lemay; Young-Jin Son
Journal:  Elife       Date:  2017-01-26       Impact factor: 8.140

2.  Blocking substance P signaling reduces musculotendinous and dermal fibrosis and sensorimotor declines in a rat model of overuse injury.

Authors:  M F Barbe; B A Hilliard; P W Fisher; A R White; S P Delany; V J Iannarone; M Y Harris; M Amin; G E Cruz; S N Popoff
Journal:  Connect Tissue Res       Date:  2019-08-23       Impact factor: 3.417

3.  Prolonged high force high repetition pulling induces osteocyte apoptosis and trabecular bone loss in distal radius, while low force high repetition pulling induces bone anabolism.

Authors:  Mary F Barbe; Vicky S Massicotte; Soroush Assari; M Alexandra Monroy; Nagat Frara; Michele Y Harris; Mamta Amin; Tamara King; Geneva E Cruz; Steve N Popoff
Journal:  Bone       Date:  2018-02-22       Impact factor: 4.398

4.  Substance P increases CCN2 dependent on TGF-beta yet Collagen Type I via TGF-beta1 dependent and independent pathways in tenocytes.

Authors:  Nagat Frara; Paul W Fisher; Yingjie Zhao; Joseph T Tarr; Mamta Amin; Steven N Popoff; Mary F Barbe
Journal:  Connect Tissue Res       Date:  2017-04-12       Impact factor: 3.417

5.  Manual therapy as an effective treatment for fibrosis in a rat model of upper extremity overuse injury.

Authors:  Geoffrey M Bove; Michele Y Harris; Huaqing Zhao; Mary F Barbe
Journal:  J Neurol Sci       Date:  2015-12-24       Impact factor: 3.181

6.  Force dependent effects of chronic overuse on fibrosis-related genes and proteins in skeletal muscles.

Authors:  Brendan A Hilliard; Mamta Amin; Steven N Popoff; Mary F Barbe
Journal:  Connect Tissue Res       Date:  2020-10-08       Impact factor: 3.417

7.  Key indicators of repetitive overuse-induced neuromuscular inflammation and fibrosis are prevented by manual therapy in a rat model.

Authors:  Mary F Barbe; Michele Y Harris; Geneva E Cruz; Mamta Amin; Nathan M Billett; Jocelynne T Dorotan; Emily P Day; Seung Y Kim; Geoffrey M Bove
Journal:  BMC Musculoskelet Disord       Date:  2021-05-05       Impact factor: 2.562

8.  CCN2 participates in overload-induced skeletal muscle hypertrophy.

Authors:  Jennifer M Petrosino; Jacob Z Longenecker; Colin D Angell; Scott A Hinger; Colton R Martens; Federica Accornero
Journal:  Matrix Biol       Date:  2022-01-16       Impact factor: 11.583

9.  Blocking CCN2 preferentially inhibits osteoclastogenesis induced by repetitive high force bone loading.

Authors:  Mary F Barbe; Mamta Amin; Anne Gingery; Alex G Lambi; Steven N Popoff
Journal:  Connect Tissue Res       Date:  2020-07-20       Impact factor: 3.417

10.  Manual therapy prevents onset of nociceptor activity, sensorimotor dysfunction, and neural fibrosis induced by a volitional repetitive task.

Authors:  Geoffrey M Bove; Sean P Delany; Lucas Hobson; Geneva E Cruz; Michele Y Harris; Mamta Amin; Susan L Chapelle; Mary F Barbe
Journal:  Pain       Date:  2019-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.